Elsevier

Life Sciences

Volume 45, Issue 22, 1989, Pages 2149-2156
Life Sciences

Osteotoxicity after chronic dietary administration of 13-cis-retinoic acid, retinyl palmitate or selenium in mice exposed to tumor initiation and promotion

https://doi.org/10.1016/0024-3205(89)90081-7Get rights and content

Abstract

In view of the clinical trials of retinoids as therapeutic agents for premalignant skin lesions, a radiographic study was undertaken to measure skeletal toxicities after chronic dietary administration of retinoids in mice exposed to tumor initiation and promotion. CD-1 mice were initiated with 0.15 moles of 7, 12-dimethylbenz[a]anthracene and promoted twice daiky with 8 nmoles of 12-0-tetradecanoylphorbol-13-acetate for 23 weeks. Diets were supplemented with 60 IU, 200 IU, or 700 IU of retinyl palmitate (RP) per g diet. After 5 weeks, the 700 IU of RP /g diet was lowered to 350 IU/g diet. Administration of these diets to mice during the 23 weeks of tumor promotion resulted in a 0-fold, 2-fold, or 10-fold increase in bone fractures, respectively. Osteoporotic bone lesions identified on radiographs rose 0-fold, 0-fold, and 10-fold at the respective doses, whereas metaphyseal flares increased 0-fold, 1.4-fold, and 3.6-fold. Bone deformities were augmented 0-fold, 1.8-fold and 2.9-fold at the respective doses. Addition of selenium (2 ppm in the drinking water) did not alter the bone toxicity of RP. 13-cis-retinoic acid (CRA) was less toxic at 700 IU/g diet than was RP at that dose, as evidenced by the death of 12 of 70 mice by the 6th week of dietary RP and no deaths in the 35 mice fed 700 IU CRA/g diet for 23 weeks. CRA at 700 IU/g diet resulted in 34 as many osteoporotic bones, 13 as many bone fractures, 45 as many metaphyseal flares, and a similar number of bone deformities as mice fed 700/350 IU/g diet. At the dose of 200 IU/g food, osteotoxicities were similar in the mice fed diets supplemented with RP and CRA. Thus, the light dose of CRA (700 IU/g diet) was less toxic than the high dose of, RP but at a lower dose (200 IU/g), CRA was as osteotoxic as was RP. Bone fractures in mice exposed to prolonged dietary administration of retinoids was a more sensitive index of retinoid toxicity than was body weight. We have detected osteotoxicity in mice at a total dose of CRA which was about twice the total dose used clinically.

References (27)

  • W. Bollag

    Europ. J. Cancer

    (1972)
  • J.J. Kamm et al.
  • G.L. Peck et al.

    Lancet

    (1976)
  • N. Wald et al.

    Lancet

    (1980)
  • E. Bjelke

    Int. J. Cancer

    (1975)
  • W. Bollag

    Chemotheraphy

    (1975)
  • J. Cahn et al.

    Acta Dermatovener. Suppl.

    (1975)
  • J.J. Digiovanna et al.

    Pediatr. Dermatol.

    (1983)
  • C.N. Ellis et al.

    Retinoids: New Trends in Research Therapy

  • H.L. GENSLER, D.A. SIM and G.T. BOWDEN, Cancer Res. 46...
  • H.L. Gensler et al.

    Cancer Res.

    (1987)
  • H.L. Gensler et al.

    Chemistry and Biology of Synthetic Retinoids

    (1988)
  • E.J. Hixson et al.

    Toxicol. Appl. Pharmacol.

    (1978)
  • Cited by (0)

    View full text